Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial evaluating rexlemestrocel-L ...
DEAR MAYO CLINIC: I've been struggling with back stiffness and pain for a long time, but it has gotten worse in the last few years. My doctor told me that I have degenerative disk disease. What ...
DEAR MAYO CLINIC: I've been struggling with back stiffness and pain for a long time, but it has gotten worse in the last few years. My doctor told me that I have degenerative disk disease. What ...
Interventional pain specialists warn spring activity aggravates back conditions and share how innovative regenerative ...
New peer-reviewed study highlights safety and clinical benefits of intradiscal MSC therapy for chronic low back pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results